Table IV.
Serum concentration of lipids – LDL-C, TC, TG, and HDL-C – at the inclusion visit and last follow-up visit in the overall population and gender subgroups, as well as the percentage reduction in serum levels throughout the observation period
| Parameter | Overall study population (N = 222) | Women (n = 159) | Men (n = 63) |
|---|---|---|---|
| TC [mmol/l] Median (interquartile range; Q1–Q3) | |||
| Inclusion visit | 8.63 (7.78–9.46) | 8.50 (7.78–9.38) | 8.81 (7.75–9.65) |
| Last follow-up visit | 5.13 (4.55–5.85) | 5.19 (4.74–5.87) | 4.81 (4.22–5.56) |
| % | –40.50 (–49.38 – –31.05)* | –39.20 (–47.25 – –29.40)^ | –44.80 (–52.35 – –36.15)^ |
| LDL-C [mmol/l] Median (interquartile range; Q1–Q3) | |||
| Inclusion visit | 6.20 (5.43–7.24) | 6.05 (5.44–6.99) | 6.54 (5.39–7.53) |
| Last follow-up visit | 2.92 (2.42–3.59) | 2.92 (2.47–3.51) | 2.92 (2.36–3.86) |
| % | –52.60 (–63.68 – –40.15)* | –51.20 (–63.50 – –39.85) | –58.50 (–65.30 – –42.30) |
| HDL-C [mmol/l] Median (interquartile range; Q1–Q3) | |||
| Inclusion visit | 1.47 (1.24–18.1) | 1.60 (1.37–1.91) | 1.27 (1.09–1.42) |
| Last follow-up visit | 1.49 (1.29–1.76) | 1.60 (1.33–1.89) | 1.32 (1.07–1.43) |
| % | –1.00 (–12.28 – 12.38) | –1.60 (–12.25 – 11.70) | 2.20 (–11.35 – 13.25) |
| TG [mmol/l] Median (interquartile range; Q1–Q3) | |||
| Inclusion visit | 1.38 (1.01–2.10) | 1.28 (0.98–2.00) | 1.62 (1.13–2.32) |
| Last follow-up visit | 1.21 (0.86–1.64) | 1.21 (0.85–1.62) | 1.15 (0.92–1.64) |
| % | –17.95 (–38.18 – 9.97)* | –14.30 (–31.45 – 14.85)^ | –28.60 (–45.30 – 4.75)^ |
LDL-C – low-density lipoprotein cholesterol, HDL-C – high-density lipoprotein cholesterol, TC – total cholesterol, TG – triglyceride.
*
Percentage reduction of concentration through the entire observation period; Statistical significance set at p < 0.001.
^
Difference in percentage reduction through the entire observation period between gender subpopulations. Statistical significance set at p < 0.05.